Dunbar Pharma is a research-driven Irish company specialising in EU cGMP-certified manufacturing of plant-derived cannabinoid APIs such as dronabinol, offering high-purity ingredients and global supply capabilities from Ireland.
Overview
Dunbar Pharma is an Ireland-based pharmaceutical manufacturer dedicated to the production of high-purity, plant-derived cannabinoid APIs under EU cGMP standards. The company combines cutting-edge research and development capabilities with rigorous quality control systems to deliver pharmaceutical-grade ingredients like dronabinol to clients worldwide. With its mission centred on safety, regulatory compliance and therapeutic consistency, Dunbar Pharma supports clients across the global healthcare and pharma sectors by providing reliable supply, full traceability and documentation. The company’s focus on innovation and quality positions it as a trusted partner for the emerging cannabinoid API market.